Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.20.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Total
Common Stock
 Additional Paid in Capital
Accumulated Deficit
Treasury Stock
Beginning balance (in shares) at Dec. 31, 2018   32,381,290      
Beginning balance at Dec. 31, 2018 $ 11,033,815 $ 32,759 $ 138,867,509 $ (126,469,894) $ (1,396,559)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (2,462,393)     (2,462,393)  
Stock-based compensation 96,871   96,871    
Stock issued for vested restricted stock awards (in shares)   186,031      
Stock issued for vested restricted stock awards 0 $ 186 (186)    
Ending balance (in shares) at Mar. 31, 2019   32,567,321      
Ending balance at Mar. 31, 2019 8,668,293 $ 32,945 138,964,194 (128,932,287) (1,396,559)
Beginning balance (in shares) at Dec. 31, 2019   51,846,011      
Beginning balance at Dec. 31, 2019 12,541,350 $ 52,223 144,843,687 (130,958,001) (1,396,559)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (2,825,236)        
Stock-based compensation 208,897   208,897    
Stock issued for vested restricted stock awards (in shares)   260,593      
Stock issued for vested restricted stock awards 0 $ 261 (261)    
Shares withheld for taxes on vest restricted stock (21,184)   (21,184)    
Convertible Note Conversion (in shares)   1,200,000      
Convertible Note Conversion 468,667 $ 1,200 467,467    
Sale of Common Stock (in shares)   7,046,429      
Sale of common stock, net 1,206,788 $ 7,046 1,199,742    
Ending balance (in shares) at Mar. 31, 2020   60,353,033      
Ending balance at Mar. 31, 2020 $ 11,579,282 $ 60,730 $ 146,698,348 $ (133,783,237) $ (1,396,559)